Literature DB >> 23200226

A novel pathway of presentation by class II-MHC molecules involving peptides or denatured proteins important in autoimmunity.

James F Mohan1, Emil R Unanue.   

Abstract

We describe here a pathway of presentation involving peptides or denatured proteins that generate unique peptide-MHC complexes. Such complexes select for non-conventional CD4 T cells. We have examined this pathway and the corresponding CD4 T cells in diabetic autoimmunity. Autoimmunity requires both the escape of self-reactive T cells from thymic selection and, importantly, suitable conditions in peripheral tissues that allow for activation of T cells. In the autoimmune diabetes of NOD mice, insulin reactive T cells are highly focused on a peptide, encompassing the 9-23 segment of the B chain (B:9-23) bound to I-A(g7). Examination of the B:9-23 reactive T cell repertoire revealed the presence of two independent sets of T cells that recognize this epitope. One set, called type A, reacted like conventional CD4 T cells, recognizing both processed insulin protein and soluble B:9-23 peptide presented by APC. These T cells were highly deleted in the thymus and poorly represented in the periphery. The second set, called type B, did not recognize processed insulin protein presented by APC, but reacted strongly to the presentation of soluble B:9-23 peptide. Notably, this set was not deleted in the thymus, abundant in the periphery and caused diabetes. Free insulin peptides generated a unique peptide-MHC complex not found after insulin processing. These two T cell subsets discriminated between two independent, overlapping registers found within the B:9-23 peptide. In the islets of Langerhans, beta cells constitutively generated proteolyzed peptides from insulin, which were taken up by intra-islet APC and presented to peptide-specific type B T cells. Thus, self-reactive T cells that escape thymic selection can become pathogenic in the target organ where high concentrations of antigen and/or differences in intracellular processing lead to the presentation of peptides bound in distinct registers from those found in the thymus.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23200226      PMCID: PMC3594457          DOI: 10.1016/j.molimm.2012.10.024

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  5 in total

Review 1.  Antigen presentation events in autoimmune diabetes.

Authors:  Boris Calderon; Emil R Unanue
Journal:  Curr Opin Immunol       Date:  2011-12-15       Impact factor: 7.486

Review 2.  Unconventional recognition of peptides by T cells and the implications for autoimmunity.

Authors:  James F Mohan; Emil R Unanue
Journal:  Nat Rev Immunol       Date:  2012-09-07       Impact factor: 53.106

3.  Unique autoreactive T cells recognize insulin peptides generated within the islets of Langerhans in autoimmune diabetes.

Authors:  James F Mohan; Matteo G Levisetti; Boris Calderon; Jeremy W Herzog; Shirley J Petzold; Emil R Unanue
Journal:  Nat Immunol       Date:  2010-02-28       Impact factor: 25.606

4.  Register shifting of an insulin peptide-MHC complex allows diabetogenic T cells to escape thymic deletion.

Authors:  James F Mohan; Shirley J Petzold; Emil R Unanue
Journal:  J Exp Med       Date:  2011-11-07       Impact factor: 14.307

5.  SENSITIZATION TO DENATURED AUTOLOGOUS GAMMA GLOBULIN.

Authors:  R T McCluskey; F Miller; B Benacerraf
Journal:  J Exp Med       Date:  1962-01-01       Impact factor: 14.307

  5 in total
  15 in total

Review 1.  A peptide's perspective on antigen presentation to the immune system.

Authors:  Jacques Neefjes; Huib Ovaa
Journal:  Nat Chem Biol       Date:  2013-12       Impact factor: 15.040

Review 2.  T cells in the control of organ-specific autoimmunity.

Authors:  Jeffrey A Bluestone; Hélène Bour-Jordan; Mickie Cheng; Mark Anderson
Journal:  J Clin Invest       Date:  2015-05-18       Impact factor: 14.808

3.  Susceptibility to HLA-DM protein is determined by a dynamic conformation of major histocompatibility complex class II molecule bound with peptide.

Authors:  Liusong Yin; Peter Trenh; Abigail Guce; Marek Wieczorek; Sascha Lange; Jana Sticht; Wei Jiang; Marissa Bylsma; Elizabeth D Mellins; Christian Freund; Lawrence J Stern
Journal:  J Biol Chem       Date:  2014-07-07       Impact factor: 5.157

Review 4.  Mechanisms of peptide repertoire selection by HLA-DM.

Authors:  Wouter Pos; Dhruv K Sethi; Kai W Wucherpfennig
Journal:  Trends Immunol       Date:  2013-07-05       Impact factor: 16.687

5.  Evaluating the Role of HLA-DM in MHC Class II-Peptide Association Reactions.

Authors:  Liusong Yin; Zachary J Maben; Aniuska Becerra; Lawrence J Stern
Journal:  J Immunol       Date:  2015-06-10       Impact factor: 5.422

6.  Monoclonal antibody blocking the recognition of an insulin peptide-MHC complex modulates type 1 diabetes.

Authors:  Li Zhang; Frances Crawford; Liping Yu; Aaron Michels; Maki Nakayama; Howard W Davidson; John W Kappler; George S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

7.  The Type 1 Diabetes-Resistance Locus Idd22 Controls Trafficking of Autoreactive CTLs into the Pancreatic Islets of NOD Mice.

Authors:  Robert L Whitener; Lisa Gallo Knight; Jianwei Li; Sarah Knapp; Shuyao Zhang; Mani Annamalai; Vadim M Pliner; Dongtao Fu; Ilian Radichev; Christina Amatya; Alexei Savinov; Arif Yurdagul; Shuai Yuan; John Glawe; Christopher G Kevil; Jing Chen; Scott E Stimpson; Clayton E Mathews
Journal:  J Immunol       Date:  2017-11-06       Impact factor: 5.422

8.  Unconventional T-cell recognition of an arthritogenic epitope of proteoglycan aggrecan released from degrading cartilage.

Authors:  Jane Falconer; Rahul Mahida; Divya Venkatesh; Jeffrey Pearson; John H Robinson
Journal:  Immunology       Date:  2015-12-21       Impact factor: 7.397

9.  Structural basis of chronic beryllium disease: linking allergic hypersensitivity and autoimmunity.

Authors:  Gina M Clayton; Yang Wang; Frances Crawford; Andrey Novikov; Brian T Wimberly; Jeffrey S Kieft; Michael T Falta; Natalie A Bowerman; Philippa Marrack; Andrew P Fontenot; Shaodong Dai; John W Kappler
Journal:  Cell       Date:  2014-07-03       Impact factor: 41.582

Review 10.  MHC Class II Auto-Antigen Presentation is Unconventional.

Authors:  Scheherazade Sadegh-Nasseri; AeRyon Kim
Journal:  Front Immunol       Date:  2015-07-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.